EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Gut Microbiome Changes in Preclinical Alzheimer’s Disease

D M Sithara Dissanayaka iD, Stephanie R Rainey-Smith iD, Hamid R Sohrabi iD, Thilini N Jayasinghe iD, Vincent Ho iD, Vijay Jayasena iD, Kevin Taddei iD, Colin L Masters iD, Ralph N Martins iD, W M A D Binosha Fernando iD

Nutrients · 29.07.2026 · 18 (15) · 2469

DOI: 10.3390/nu18152469 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 29.07.2026. Verfasst von D M Sithara Dissanayaka und 9 weiteren Autor:innen. Beteiligte Einrichtung: Centre of Excellence for Alzheimer's Disease Research & Care, School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA 6027, Aust…. Hauptthemen laut MEDLINE: Alzheimer Disease, Gastrointestinal Microbiome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 208 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that develops many years before clinical symptoms appear. The biological changes involved in the earliest stages remain poorly understood, particularly during the preclinical stage. Our previous work has identified gradual gut microbial and metabolic changes during this stage, suggesting these may represent early biological shifts that precede disease progression. Recent studies suggest that the gut microbiome may contribute to early AD processes through its effects on immune regulation, metabolism, and gut–brain communication. Changes in gut microbial composition, including reduced levels of short-chain fatty acid (SCFA)-producing bacteria, such as Faecalibacterium, Roseburia, and Eubacterium, have been reported in individuals with AD and mild cognitive impairment. These microbial alterations have also been linked to disrupted metabolic activity, impaired gut barrier function, and increased neuroinflammatory responses. Diet is an important factor influencing gut microbial composition and metabolic activity. Mediterranean, DASH, and prudent dietary patterns are generally associated with beneficial microbial profiles and increased SCFA production, whereas Western dietary patterns are linked to lower microbial diversity and increased pro-inflammatory taxa. This review summarises the current evidence linking gut microbiota, SCFAs, microbial metabolism, and dietary patterns with early AD pathology, while highlighting important gaps in the existing literature.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseGastrointestinal MicrobiomeHumansFatty Acids, VolatileAnimalsDietBrain

Stichwörter der Autor:innen

Alzheimer’s diseasedietary patternsgut microbiomegut–brain axisneuroinflammationpreclinicalshort-chain fatty acids

Substanzen

Fatty Acids, Volatile

Autor:innen und Institutionen

  • Centre of Excellence for Alzheimer's Disease Research & Care, School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA 6027, Australia.
  • Alzheimer's Research Australia, Ralph and Patricia Sarich Neuroscience Research Institute, Nedlands, WA 6009, Australia.
  • Centre for Healthy Ageing, Murdoch University, Murdoch, WA 6150, Australia.
  • Department of Biomedical Sciences, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW 2109, Australia.
  • Sydney Dental School, Faculty of Medicine and Health, University of Sydney, Camperdown, NSW 2050, Australia.
  • Oral Health Services, Western Sydney Local Health District, Westmead, NSW 2151, Australia.

ORCID-Profile: D M Sithara Dissanayaka, Stephanie R Rainey-Smith, Hamid R Sohrabi, Thilini N Jayasinghe, Vincent Ho, Vijay Jayasena, Kevin Taddei, Colin L Masters, Ralph N Martins, W M A D Binosha Fernando

Zitieren

APA

Dissanayaka, D. M. S., Rainey-Smith, S. R., Sohrabi, H. R., Jayasinghe, T. N., Ho, V., Jayasena, V., Taddei, K., Masters, C. L., Martins, R. N., & Fernando, W. M. A. D. B. (2026). Gut Microbiome Changes in Preclinical Alzheimer’s Disease. Nutrients, 18(15), 2469. https://doi.org/10.3390/nu18152469

Vancouver

Dissanayaka DMS, Rainey-Smith SR, Sohrabi HR, Jayasinghe TN, Ho V, Jayasena V, et al. Gut Microbiome Changes in Preclinical Alzheimer’s Disease. Nutrients. 2026;18(15):2469. doi:10.3390/nu18152469

BibTeX
@article{Dissanayaka2026,
  author = {Dissanayaka, D M Sithara and Rainey-Smith, Stephanie R and Sohrabi, Hamid R and Jayasinghe, Thilini N and Ho, Vincent and Jayasena, Vijay and Taddei, Kevin and Masters, Colin L and Martins, Ralph N and Fernando, W M A D Binosha},
  title = {Gut Microbiome Changes in Preclinical Alzheimer’s Disease},
  journal = {Nutrients},
  year = {2026},
  volume = {18},
  number = {15},
  pages = {2469},
  doi = {10.3390/nu18152469}
}
Kostenlos starten →